Corcept Therapeutics (CORT) Inspires Confidence with ROSELLA Phase 3 Survival Data
Summary
On April 11, Corcept Therapeutics Inc.
Description
On April 11, Corcept Therapeutics Inc.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source